Treatment Of Diabetes Is Different For Men And Women.
Widely employed diabetes drugs have distinct crap on men's and women's hearts, a untrained study suggests. Researchers examined how three commonly prescribed treatments for species 2 diabetes affected 78 patients who were divided into three groups. One categorize took metformin alone, the aid group took metformin additional rosiglitazone (sold under the brand name Avandia) and the third collect took metformin plus Lovaza, a type of fish oil pro extender v2 vs v3. Metformin reduces blood sugar manufacture by the liver and improves insulin sensitivity.
Rosiglitazone also improves insulin receptivity and moves set free fatty acids out of the blood. Lovaza lowers blood levels of another ilk of fat called triglycerides. The researchers found that the drugs had very several and sometimes opposite effects on the hearts of men and women, even as the drugs controlled blood sugar equally well in both genders. The investigate appears in the December version of the American Journal of Physiology - Heart and Circulatory Physiology.
Showing posts with label metformin. Show all posts
Showing posts with label metformin. Show all posts
Sunday, February 17, 2019
Monday, April 4, 2016
Obesity Getting Younger In The United States
Obesity Getting Younger In The United States.
Obese children who don't have variety 2 diabetes but interpret the diabetes numb metformin while improving their fast and exercise habits seem to lose a bit of weight. But it isn't much more charge than kids who only make the lifestyle changes, according to a new consider of studies. Some evidence suggests that metformin, in organization with lifestyle changes, affects weight loss in obese children cirrhosis. But the cure-all isn't likely to result in important reductions in weight, said chain researcher Marian McDonagh.
Childhood paunchiness is a significant health problem in the United States, with nearly 18 percent of kids between 6 and 19 years close classified as obese. Metformin is approved by the US Food and Drug Administration to manage prototype 2 diabetes in adults and children over 10 years old, but doctors have old it "off-label" to treat tubby kids who don't have diabetes, according to background information included in the study.
McDonagh's troupe analyzed 14 clinical trials that included nearly 1000 children between 10 and 16 years old. All were overweight or obese. Based on observations in adults, load reductions of 5 percent to 10 percent are needed to wane the chance of serious health problems tied to obesity, the researchers said. The additional magnitude of weight wasting among children taking metformin in the review, however, was less than 5 percent on average.
Obese children who don't have variety 2 diabetes but interpret the diabetes numb metformin while improving their fast and exercise habits seem to lose a bit of weight. But it isn't much more charge than kids who only make the lifestyle changes, according to a new consider of studies. Some evidence suggests that metformin, in organization with lifestyle changes, affects weight loss in obese children cirrhosis. But the cure-all isn't likely to result in important reductions in weight, said chain researcher Marian McDonagh.
Childhood paunchiness is a significant health problem in the United States, with nearly 18 percent of kids between 6 and 19 years close classified as obese. Metformin is approved by the US Food and Drug Administration to manage prototype 2 diabetes in adults and children over 10 years old, but doctors have old it "off-label" to treat tubby kids who don't have diabetes, according to background information included in the study.
McDonagh's troupe analyzed 14 clinical trials that included nearly 1000 children between 10 and 16 years old. All were overweight or obese. Based on observations in adults, load reductions of 5 percent to 10 percent are needed to wane the chance of serious health problems tied to obesity, the researchers said. The additional magnitude of weight wasting among children taking metformin in the review, however, was less than 5 percent on average.
Tuesday, November 26, 2013
Sulfonylurea Drugs Increase The Risk Of Heart Disease
Sulfonylurea Drugs Increase The Risk Of Heart Disease.
New exploration shows that older the crowd with exemplar 2 diabetes who take drugs known as sulfonylureas to further their blood sugar levels may face a higher danger for heart problems than their counterparts who take metformin. Of the more than 8500 masses aged 65 or older with genus 2 diabetes who were enrolled in the trial, 12,4 percent of those given a sulfonylurea pharmaceutical experienced a heart attack or other cardiovascular event, compared with 10,4 percent of those who were started on metformin med world plus. In addition, these bravery problems occurred earlier in the headway of treatment mid those people taking the sulfonylurea drugs, the study showed.
The head-to-head match trial is slated to be presented Saturday at the American Diabetes Association annual convention in San Diego. Because the findings are being reported at a medical meeting, they should be considered overture until published in a peer-reviewed journal. With classification 2 diabetes, the body either does not occasion enough of the hormone insulin or doesn't use the insulin it does produce properly.
In either case, the insulin can't do its job, which is to make over glucose (blood sugar) to the body's cells. As a result, glucose builds up in the blood and can exercise mayhem on the body. Metformin and sulfonylurea drugs - the latter a realm of diabetes drugs including glyburide, glipizide, chlorpropamide, tolbutamide and tolazamide - are often amidst the in the first place medications prescribed to lower blood sugar levels in populate with type 2 diabetes.
The findings are important, the researchers noted, partly because sulfonylurea drugs are commonly prescribed middle the past it to lower blood glucose levels. In addition, cardiovascular contagion is the leading cause of death amid people with type 2 diabetes. For several reasons, however, the fresh study on these medications is far from the final word on the issue, experts said.
For one, occupy who are started on the sulfonylureas a substitute of metformin are often sicker to begin with, said Dr Spyros G Mezitis, an endocrinologist at Lenox Hill Hospital in New York City. Metformin cannot be prescribed to bourgeoisie with absolute kidney and nerve problems, he said. Both medications debase blood glucose levels, but go about it in entirely different ways, he explained.
New exploration shows that older the crowd with exemplar 2 diabetes who take drugs known as sulfonylureas to further their blood sugar levels may face a higher danger for heart problems than their counterparts who take metformin. Of the more than 8500 masses aged 65 or older with genus 2 diabetes who were enrolled in the trial, 12,4 percent of those given a sulfonylurea pharmaceutical experienced a heart attack or other cardiovascular event, compared with 10,4 percent of those who were started on metformin med world plus. In addition, these bravery problems occurred earlier in the headway of treatment mid those people taking the sulfonylurea drugs, the study showed.
The head-to-head match trial is slated to be presented Saturday at the American Diabetes Association annual convention in San Diego. Because the findings are being reported at a medical meeting, they should be considered overture until published in a peer-reviewed journal. With classification 2 diabetes, the body either does not occasion enough of the hormone insulin or doesn't use the insulin it does produce properly.
In either case, the insulin can't do its job, which is to make over glucose (blood sugar) to the body's cells. As a result, glucose builds up in the blood and can exercise mayhem on the body. Metformin and sulfonylurea drugs - the latter a realm of diabetes drugs including glyburide, glipizide, chlorpropamide, tolbutamide and tolazamide - are often amidst the in the first place medications prescribed to lower blood sugar levels in populate with type 2 diabetes.
The findings are important, the researchers noted, partly because sulfonylurea drugs are commonly prescribed middle the past it to lower blood glucose levels. In addition, cardiovascular contagion is the leading cause of death amid people with type 2 diabetes. For several reasons, however, the fresh study on these medications is far from the final word on the issue, experts said.
For one, occupy who are started on the sulfonylureas a substitute of metformin are often sicker to begin with, said Dr Spyros G Mezitis, an endocrinologist at Lenox Hill Hospital in New York City. Metformin cannot be prescribed to bourgeoisie with absolute kidney and nerve problems, he said. Both medications debase blood glucose levels, but go about it in entirely different ways, he explained.
Subscribe to:
Posts (Atom)